{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:08:43Z","timestamp":1773864523493,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T00:00:00Z","timestamp":1195084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T00:00:00Z","timestamp":1195084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s10557-007-6068-5","type":"journal-article","created":{"date-parts":[[2007,11,14]],"date-time":"2007-11-14T01:54:47Z","timestamp":1195005287000},"page":"423-429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Differences in the Effect of Angiotensin-converting Enzyme Inhibitors on the Rate of Endothelial Cell Apoptosis: In Vitro and In Vivo Studies"],"prefix":"10.1007","volume":"21","author":[{"given":"C.","family":"Ceconi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Francolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bastianon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.L.","family":"Gitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Comini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,11,15]]},"reference":[{"key":"6068_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0895-7061(99)00213-7","volume":"13","author":"M Buemi","year":"2000","unstructured":"Buemi M, Corica F, Marino D, et al. Cardiovascular remodeling, apoptosis, and drugs. Am J Hypertens. 2000;13:450\u20134.","journal-title":"Am J Hypertens"},{"key":"6068_CR2","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","volume":"47","author":"E Falk","year":"2006","unstructured":"Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47:C7\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"6068_CR3","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","volume":"362","author":"The European Reduction Of cardiac events with Perindopril in stable coronary Artery disease Investigators","year":"2003","unstructured":"The European Reduction Of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782\u20138.","journal-title":"Lancet"},{"key":"6068_CR4","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1185\/030079904X4185","volume":"20","author":"ME Bertrand","year":"2004","unstructured":"Bertrand ME. Provision of cardiovascular protection by ACE inhibitors: a review of recent trials. Curr Med Res Opin. 2004;20:1559\u201369.","journal-title":"Curr Med Res Opin"},{"key":"6068_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cardiores.2006.10.021","volume":"73","author":"C Ceconi","year":"2007","unstructured":"Ceconi C, Fox KM, Remme WJ, et al. ACE inhibition with perindopril and endothelial dysfunction. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res. 2007;73:237\u201346.","journal-title":"Cardiovasc Res"},{"key":"6068_CR6","first-page":"109","volume":"43","author":"S Moncada","year":"1991","unstructured":"Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109\u201342.","journal-title":"Pharmacol Rev"},{"key":"6068_CR7","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","volume":"329","author":"S Moncada","year":"1993","unstructured":"Moncada S, Higgs A. The l-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002\u201312.","journal-title":"N Engl J Med"},{"key":"6068_CR8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.CIR.102.3.351","volume":"102","author":"R Varin","year":"2000","unstructured":"Varin R, Mulder P, Tamion F, et al. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin. Circulation. 2000;102:351\u20136.","journal-title":"Circulation"},{"key":"6068_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.RES.0000121103.03275.EC","volume":"94","author":"H Ohashi","year":"2004","unstructured":"Ohashi H, Takagi H, Oh H, et al. Phosphatidylinositol 3-kinase\/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity. Circ Res. 2004;94:785\u201393.","journal-title":"Circ Res"},{"key":"6068_CR10","first-page":"H1927","volume":"276","author":"T Takahashi","year":"1999","unstructured":"Takahashi T, Taniguchi T, Konishi H, Kikkawa U, Ishikawa Y, Yokoyama M. Activation of Akt\/protein kinase B after stimulation with angiotensin II in vascular smooth muscle cells. Am J Physiol. 1999;276:H1927\u2013H1934.","journal-title":"Am J Physiol"},{"key":"6068_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1006\/bbrc.1998.9189","volume":"250","author":"W Li","year":"1998","unstructured":"Li W, Ye Y, Fu B, et al. Genetic deletion of AT2 receptor antagonizes angiotensin II-induced apoptosis in fibroblasts of the mouse embryo. Biochem Biophys Res Commun. 1998;250:72\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"6068_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1006\/excr.1997.3477","volume":"231","author":"E Cigola","year":"1997","unstructured":"Cigola E, Kajstura J, Li B, Meggs LG, Anversa P. Angiotensin II activates programmed myocyte cell death in vitro. Exp Cell Res. 1997;231:363\u201371.","journal-title":"Exp Cell Res"},{"key":"6068_CR13","doi-asserted-by":"crossref","first-page":"F955","DOI":"10.1152\/ajprenal.00246.2002","volume":"284","author":"M Bhaskaran","year":"2003","unstructured":"Bhaskaran M, Reddy K, Radhakrishanan N, Franki N, Ding G, Singhal PC. Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol. 2003;284:F955\u2013F965.","journal-title":"Am J Physiol Renal Physiol"},{"key":"6068_CR14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.RES.79.4.748","volume":"79","author":"MJ Pollman","year":"1996","unstructured":"Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ Res. 1996;79:748\u201356.","journal-title":"Circ Res"},{"key":"6068_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0304-3940(97)00605-8","volume":"232","author":"Y Kakinuma","year":"1997","unstructured":"Kakinuma Y, Hama H, Sugiyama F, Goto K, Murakami K, Fukamizu A. Anti-apoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knock-out mice. Neurosci Lett. 1997;232:167\u201370.","journal-title":"Neurosci Lett"},{"key":"6068_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0021-9150(99)00122-7","volume":"146","author":"M Nakamura","year":"1999","unstructured":"Nakamura M, Tanaka M, Abe S, Fujiwara H. Sudden pressure elevation can trigger acute muscle cell death of the heart and aorta. Atherosclerosis. 1999;146:25\u201332.","journal-title":"Atherosclerosis"},{"key":"6068_CR17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/01.HYP.34.2.229","volume":"34","author":"BS Tea","year":"1999","unstructured":"Tea BS, Dam TV, Moreau P, Hamet P, deBlois D. Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity. Hypertension. 1999;34:229\u201335.","journal-title":"Hypertension"},{"key":"6068_CR18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.RES.82.5.619","volume":"82","author":"A Otani","year":"1998","unstructured":"Otani A, Takagi H, Suzuma K, Honda Y. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res. 1998;82:619\u201328.","journal-title":"Circ Res"},{"key":"6068_CR19","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.RES.81.6.970","volume":"81","author":"S Dimmeler","year":"1997","unstructured":"Dimmeler S, Rippmann V, Weiland U, Haendeler J, Zeiher AM. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res. 1997;81:970\u20136.","journal-title":"Circ Res"},{"key":"6068_CR20","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1161\/01.HYP.0000165308.04703.f2","volume":"45","author":"M Akishita","year":"2005","unstructured":"Akishita M, Nagai K, Xi H, et al. Renin-angiotensin system modulates oxidative stress-induced endothelial cell apoptosis in rats. Hypertension. 2005;45:1188\u201393.","journal-title":"Hypertension"},{"key":"6068_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1006\/mpat.1997.0178","volume":"24","author":"EA Frey","year":"1998","unstructured":"Frey EA, Finlay BB. Lipopolysaccharide induces apoptosis in a bovine endothelial cell line via a soluble CD14 dependent pathway. Microb Pathog. 1998;24:101\u20139.","journal-title":"Microb Pathog"},{"key":"6068_CR22","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1097\/00003246-200205001-00009","volume":"30","author":"RS Hotchkiss","year":"2002","unstructured":"Hotchkiss RS, Tinsley KW, Swanson PE, Karl IE. Endothelial cell apoptosis in sepsis. Crit Care Med. 2002;30:S225\u2013S228.","journal-title":"Crit Care Med"},{"key":"6068_CR23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jlb.59.2.241","volume":"59","author":"Z Yang","year":"1996","unstructured":"Yang Z, Breider MA, Carroll RC, Miller MS, Bochsler PN. Soluble CD14 and lipopolysaccharide-binding protein from bovine serum enable bacterial lipopolysaccharide-mediated cytotoxicity and activation of bovine vascular endothelial cells in vitro. J Leukoc Biol. 1996;59:241\u20137.","journal-title":"J Leukoc Biol"},{"key":"6068_CR24","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1128\/iai.61.8.3149-3156.1993","volume":"61","author":"M Arditi","year":"1993","unstructured":"Arditi M, Zhou J, Dorio R, Rong GW, Goyert SM, Kim KS. Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14. Infect Immun. 1993;61:3149\u201356.","journal-title":"Infect Immun"},{"key":"6068_CR25","doi-asserted-by":"crossref","first-page":"L899","DOI":"10.1152\/ajplung.00338.2002","volume":"284","author":"DD Bannerman","year":"2003","unstructured":"Bannerman DD, Goldblum SE. Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol. 2003;284:L899\u2013L914.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"6068_CR26","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI107470","volume":"52","author":"EA Jaffe","year":"1973","unstructured":"Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745\u201356.","journal-title":"J Clin Invest"},{"key":"6068_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0014-5793(99)00378-6","volume":"448","author":"HJ Kwak","year":"1999","unstructured":"Kwak HJ, So JN, Lee SJ, Kim I, Koh GY. Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett. 1999;448:249\u201353.","journal-title":"FEBS Lett"},{"key":"6068_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.phrs.2007.03.004","volume":"56","author":"L Comini","year":"2007","unstructured":"Comini L, Bachetti T, Cargnoni A, et al. Therapeutic modulation of the nitric oxide pathway: are all ACE inhibitors equivalent. Pharmacol Res. 2007;56:42\u20138.","journal-title":"Pharmacol Res"},{"key":"6068_CR29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.RES.86.1.24","volume":"86","author":"I Kim","year":"2000","unstructured":"Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase\/Akt signal transduction pathway. Circ Res. 2000;86:24\u20139.","journal-title":"Circ Res"},{"key":"6068_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1023\/A:1015709617405","volume":"16","author":"VJ Dzau","year":"2002","unstructured":"Dzau VJ, Bernstein K, Celermajer D, et al. Pathophysiologic and therapeutic importance of tissue ACE: a consensus report. Cardiovasc Drugs Ther. 2002;16:149\u201360.","journal-title":"Cardiovasc Drugs Ther"},{"key":"6068_CR31","first-page":"III628","volume":"110","author":"WJ Remme","year":"2004","unstructured":"Remme WJ. Prevention of cardiovascular events by perindopril in patients with stable coronary disease does not depend on blood pressure and its reduction\u2014results from the EUROPA study. Circulation. 2004;110:III628Abstract.","journal-title":"Circulation"},{"key":"6068_CR32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.phrs.2004.11.001","volume":"51","author":"L Comini","year":"2005","unstructured":"Comini L, Boraso A, Bachetti T, et al. Effects of endotoxic shock on neuronal NOS and calcium transients in rat cardiac myocytes. Pharmacol Res. 2005;51:409\u201317.","journal-title":"Pharmacol Res"},{"key":"6068_CR33","first-page":"L717","volume":"275","author":"GD Ceneviva","year":"1998","unstructured":"Ceneviva GD, Tzeng E, Hoyt DG, et al. Nitric oxide inhibits lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells. Am J Physiol. 1998;275:L717\u2013L728.","journal-title":"Am J Physiol"},{"key":"6068_CR34","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archsurg.1997.01430330043006","volume":"132","author":"E Tzeng","year":"1997","unstructured":"Tzeng E, Billiar TR. Nitric oxide and the surgical patient. Identifying therapeutic targets. Arch Surg. 1997;132:977\u201382.","journal-title":"Arch Surg"},{"key":"6068_CR35","doi-asserted-by":"crossref","first-page":"R1092","DOI":"10.1152\/ajpregu.00700.2002","volume":"284","author":"M Miyoshi","year":"2003","unstructured":"Miyoshi M, Nagata K, Imoto T, Goto O, Ishida A, Watanabe T. ANG II is involved in the LPS-induced production of proinflammatory cytokines in dehydrated rats. Am J Physiol Regul Integr Comp Physiol. 2003;284:R1092\u2013R1097.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"6068_CR36","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/sj.bjp.0703489","volume":"130","author":"SF Luo","year":"2000","unstructured":"Luo SF, Wang CC, Chiu CT, et al. Lipopolysaccharide enhances bradykinin-induced signal transduction via activation of Ras\/Raf\/MEK\/MAPK in canine tracheal smooth muscle cells. Br J Pharmacol. 2000;130:1799\u2013808.","journal-title":"Br J Pharmacol"},{"key":"6068_CR37","doi-asserted-by":"publisher","first-page":"8022","DOI":"10.1074\/jbc.M407179200","volume":"280","author":"H Yin","year":"2005","unstructured":"Yin H, Chao L, Chao J. Kallikrein\/kinin protects against myocardial apoptosis after ischemia\/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. J Biol Chem. 2005;280:8022\u201330.","journal-title":"J Biol Chem"},{"key":"6068_CR38","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/sj.cdd.4400581","volume":"6","author":"S Dimmeler","year":"1999","unstructured":"Dimmeler S, Zeiher AM. Nitric oxide\u2014an endothelial cell survival factor. Cell Death Differ. 1999;6:964\u20138.","journal-title":"Cell Death Differ"},{"key":"6068_CR39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/biof.5520110404","volume":"11","author":"N Fujita","year":"2000","unstructured":"Fujita N, Manabe H, Yoshida N, et al. Inhibition of angiotensin-converting enzyme protects endothelial cell against hypoxia\/reoxygenation injury. Biofactors. 2000;11:257\u201366.","journal-title":"Biofactors"},{"key":"6068_CR40","doi-asserted-by":"publisher","first-page":"31437","DOI":"10.1074\/jbc.273.47.31437","volume":"273","author":"YM Kim","year":"1998","unstructured":"Kim YM, Kim TH, Seol DW, Talanian RV, Billiar TR. Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. J Biol Chem. 1998;273:31437\u201341.","journal-title":"J Biol Chem"},{"key":"6068_CR41","doi-asserted-by":"publisher","first-page":"31138","DOI":"10.1074\/jbc.272.49.31138","volume":"272","author":"YM Kim","year":"1997","unstructured":"Kim YM, Talanian RV, Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem. 1997;272:31138\u201348.","journal-title":"J Biol Chem"},{"key":"6068_CR42","doi-asserted-by":"publisher","first-page":"17325","DOI":"10.1074\/jbc.274.24.17325","volume":"274","author":"J Li","year":"1999","unstructured":"Li J, Bombeck CA, Yang S, Kim YM, Billiar TR. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes. J Biol Chem. 1999;274:17325\u201333.","journal-title":"J Biol Chem"},{"key":"6068_CR43","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1006\/bbrc.1997.7304","volume":"238","author":"S Mohr","year":"1997","unstructured":"Mohr S, Zech B, Lapetina EG, Brune B. Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochem Biophys Res Commun. 1997;238:387\u201391.","journal-title":"Biochem Biophys Res Commun"},{"key":"6068_CR44","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/41237","volume":"388","author":"G Melino","year":"1997","unstructured":"Melino G, Bernassola F, Knight RA, Corasaniti MT, Nistico G, Finazzi-Agro A. S-nitrosylation regulates apoptosis. Nature. 1997;388:432\u20133.","journal-title":"Nature"},{"key":"6068_CR45","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1074\/jbc.274.11.6823","volume":"274","author":"L Rossig","year":"1999","unstructured":"Rossig L, Fichtlscherer B, Breitschopf K, et al. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem. 1999;274:6823\u20136.","journal-title":"J Biol Chem"},{"key":"6068_CR46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/bbrc.1997.7672","volume":"240","author":"J Li","year":"1997","unstructured":"Li J, Billiar TR, Talanian RV, Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun. 1997;240:419\u201324.","journal-title":"Biochem Biophys Res Commun"},{"key":"6068_CR47","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/sj.cdd.4400578","volume":"6","author":"L Liu","year":"1999","unstructured":"Liu L, Stamler JS. NO: an inhibitor of cell death. Cell Death Differ. 1999;6:937\u201342.","journal-title":"Cell Death Differ"},{"key":"6068_CR48","doi-asserted-by":"publisher","unstructured":"Ceconi C, Francolini G, Olivares A, Comini L, Bachetti T, Ferrari R. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. Eur J Pharmacol 2007 DOI 10.1016\/j.ejphar.2007.07.061","DOI":"10.1016\/j.ejphar.2007.07.061"},{"key":"6068_CR49","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.cca.2005.07.021","volume":"364","author":"W Yu","year":"2006","unstructured":"Yu W, Akishita M, Xi H, et al. Angiotensin converting enzyme inhibitor attenuates oxidative stress-induced endothelial cell apoptosis via p38 MAP kinase inhibition. Clin Chim Acta. 2006;364:328\u201334.","journal-title":"Clin Chim Acta"},{"key":"6068_CR50","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/01.fjc.0000175234.95831.3e","volume":"46","author":"AS Galvez","year":"2005","unstructured":"Galvez AS, Fiedler JL, Ocaranza MP, Jalil JE, Lavandero S, Diaz-Araya G. Perindopril regulates beta-agonist-induced cardiac apoptosis. J Cardiovasc Pharmacol. 2005;46:255\u201361.","journal-title":"J Cardiovasc Pharmacol"},{"key":"6068_CR51","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S1065-6995(03)00162-8","volume":"27","author":"A Mailloux","year":"2003","unstructured":"Mailloux A, Deslandes B, Vaubourdolle M, Baudin B. Captopril and enalaprilat decrease antioxidant defences in human endothelial cells and are unable to protect against apoptosis. Cell Biol Int. 2003;27:825\u201330.","journal-title":"Cell Biol Int"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-007-6068-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-007-6068-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-007-6068-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-007-6068-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T23:41:00Z","timestamp":1652658060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-007-6068-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,15]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["6068"],"URL":"https:\/\/doi.org\/10.1007\/s10557-007-6068-5","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,15]]},"assertion":[{"value":"8 October 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}